The screen credited BILL with a 31.6% demonstrated revenue CAGR against a required 15.3%, a +16.3pp margin. Both numbers are wrong, in opposite directions. The 31.6% is the FY2022–FY2025 window — thirteen months stale, with 18.7% of the growth inside it supplied by float interest rather than operations; the current run rate is 12.5%. And the scanner's net cash of −$840.2m omitted $1,178.7m of short-term investments sitting directly beneath cash on the same balance sheet; verified net cash is +$338.5m, which cuts enterprise value from $5,454m to $4,279m and the required CAGR from 15.3% to 9.8%. The margin the strategy ranks on is +2.7pp, not +16.3pp. Only 17.9% of BILL's revenue is recurring software subscription; 72.7% is per-payment fees and supplier interchange and 9.4% is interest on ~$4.0bn of customer money in transit.
How to read this
This is an analysis, not a position. The memo scores every Criteria and blocks on none of them. Whether an analysis justifies a position is a question about a particular book, so this page carries no Long, Short, Watchlist or Avoid verdict.
Every Criteria returns PASS / FAIL / INDETERMINATE, and carries a type. BINDING criteria are admission tests for a long-only absolute-return strategy. MEASURED criteria are always scored and stored and never block. A missing input is INDETERMINATE, never FAIL.
Two valuation outputs, over two horizons. The implied-path test (reverse DCF) asks what today's price requires over five years and whether the business has demonstrated it. The 12-month target asks what the name is likely to trade at, on near-term estimates and the name's own multiple history with the percentile stated. Neither replaces the other. Sensitivity is run over the exit multiple, never over scenario probabilities.
Momentum is entry timing only — when to enter a position the thesis already justifies, never whether to own one.
Key findings
- Only 17.9% of BILL's revenue is recurring software subscription. 72.7% is per-payment fees and supplier interchange, 9.4% is interest on ~$4.0bn of customer money in transit. The screen priced a payments company on a software multiple.
- The screen's 31.6% 'demonstrated CAGR' is the FY2022-FY2025 window — 13 months stale, and 18.7% of the revenue growth inside it is float interest. Ex-float the same window is 27.1%; the current run rate is 12.5% total and 15.4% core, and the company guides FY2026 to +12-13%.
- The scanner's net cash of -$840.2m omitted the $1,178.7m short-term investments line. Verified +$338.5m. EV falls from $5,454m to $4,279m, EV/Sales from 3.41x to 2.67x, and the required CAGR from 15.3% to 9.8%.
- Net result: the margin (demonstrated - required) is +2.7pp, not +16.3pp — a six-fold overstatement of the variable the strategy ranks on, produced by two errors of opposite sign.
- Net dollar-based retention was 94%, 92% and 111% in FY2025, FY2024 and FY2023. Below 100% for two years: the installed BILL AP/AR base shrinks in revenue terms and all growth is new logos, at ~86% logo retention.
- Businesses using BILL's solutions fell sequentially from 498,500 to 493,800 in the March-2026 quarter, the first decline in eight quarters. Year-over-year growth is +1.1%.
- The mechanism is take-rate expansion, and it is real and positive: transaction fees / TPV went 28.2bp to 33.3bp in eight quarters, FY2024 29.6bp to FY2025 31.2bp. Latest quarter: transaction fees +18% = TPV +12% x take rate +5%. Take-rate direction is UP.
- The acquisition hypothesis was tested and rejected: Divvy closed 1 June 2021 and Invoice2go 1 September 2021, so the FY2022 CAGR base already contains both; goodwill has been unchanged at $2,396,509k since FY2024.
- Broken story or overcorrection? Neither cleanly. At 2.67x EV/Sales the exit multiple implies an exit EV/Sales of 2.70x — the price embeds essentially ZERO multiple change and asks only for low-double-digit growth and an eventual 11.2% GAAP EBIT margin. The opportunity, if any, is that BILL sits at the 30th percentile of its OWN multiple range since January 2025, which is a 12-month trade rather than a five-year valuation argument.
- Everything resolves against one filing roughly four weeks out: the Q4/FY2026 results and first FY2027 guide, expected late August 2026, which carry the FY2026 NDR, the year-end customer count, the FY2026 take rate and the first float assumption set into a cutting cycle.
Sections
Disclosed limitations
- The exit multiple of 24.1x EBIT is taken from the screen and its comparator set was NOT rebuilt. BILL is SIC 7372 (software) while 82.1% of its revenue is payments and float, so the growth-matched anchor is very likely drawn from the wrong industry, in the expensive direction. The break-even is 21.3x. This is the dominant unresolved input and the first thing a reviewer should attack.
- Peer Spread Criteria is INDETERMINATE — no peer multiples were pulled for Corpay, WEX, Marqeta or Toast.
- Consensus Criteria is INDETERMINATE — the Alpha Vantage shared 25/day quota was exhausted.
- The terminal margin of 11.2% is the screen's 'industry median (pre-profit)' and was not independently derived.
- The Street mean target of ~$53.91 is press-sourced and unverified; used only as a sanity band, never as a calibration input.
- Starboard Value's stake size, board seats, any strategic-alternatives review, private-equity interest, a 30% workforce reduction, a new Chief Revenue Officer and analyst initiations are ALL press-reported. No SC 13D appears in BILL's recent EDGAR filing index. A campaign is evidenced (DFAN14A filed 2025-09-08; 'activism' appears seven times in each of the last three earnings releases and zero times before); its terms are not. None of it is used in the valuation.
- The mention-frequency series in BILL_Research.md section 6 is built from BILL's quarterly earnings PRESS RELEASES, not call transcripts. No verified transcript source was available in the time box. It measures what management puts in writing under Reg FD — a narrower instrument than the Q&A — and is labelled as such.
- Q3 and Q4 FY2024 subscription fees ($65.6m, $65.8m) are derived by residual from the FY2024 total and stated growth rates; approximate.
- Implied take rates are computed against TPV reported rounded to the whole $bn: +/-0.4bp precision. The direction is robust; individual quarters are not.
- The Q4 FY2026 earnings date is NOT announced. The catalyst calendar gives the prior three years' actual filing dates and labels the expectation as an inference.
- The own-multiple EV/Sales series holds the CURRENT share count and net cash fixed against as-known TTM revenue, so it measures multiple movement rather than historical enterprise value exactly.
- Ramp, Brex and Navan are named as the competitive set for BILL Spend and Expense on general knowledge. All are private; no filings; no numbers asserted.